1, Kewa Bio: semi-automatic biochemistry, automatic biochemistry
According to the company's diagnostic instruments and reagents synchronous development strategy, the company's medical instrument business is rapidly advancing, the "excellence" automatic biochemistry analyzers basically formed a series of eight products have been marketed to meet the needs of users at different levels, and also in line with the new health care system. The "Excellence" automatic biochemistry analyzer has basically formed a series, with eight products on the market, which not only meets the needs of users at different levels, but also conforms to the trend of the new healthcare reform, which has led to a large number of primary medical institutions being equipped with instruments. The rapid growth of diagnostic instrument business has increased the proportion of instruments in the company's overall business composition: since this year, the demand for diagnostic instruments has been accelerated and released with the support of policies, the government's investment in medical service providers is direct and rapid, and in the reallocation of medical resources, the demand for basic diagnostic and therapeutic equipment in various types of medical institutions has increased. Benefiting from this, the company's main instrument products have maintained rapid growth.
2, Neusoft shares: medical imaging equipment
Company holding 67% of Shenyang Neusoft, is China's only at the same time have CT, magnetic *** vibration, digital X-ray machine, color ultrasound, all four high-tech imaging equipment enterprises. Neusoft Corporation successfully developed China's first medical whole-body CT in 1997, and successfully developed spiral CT in April 2000, and successively obtained ISO9001, European CE certification and U.S. FDA certification, and successively filled the gaps of similar products in China for five times, with nearly 30 varieties of products in seven categories, and the domestic market share of open magnetic *** vibration and CT has ranked first and second. The digital medical equipment business has become the most important source of revenue for Neusoft Corporation.
3, and good shares: minimally invasive tumor treatment equipment
The company focuses on the domestic medical equipment market, the current self-produced products have 3 plates 18 varieties of 43 models, the application area covers minimally invasive treatment of tumors, medical molecular sieve oxygenation and engineering and conventional diagnostic and treatment (including physical therapy, treatment and medical imaging), the company is also engaged in the distribution of medical equipment agent business, is the first and second largest medical imaging field government procurement in the medical imaging field. The Company is also engaged in the business of medical equipment agency and distribution, and is one of the largest equipment suppliers in terms of bidding volume and winning amount in the government procurement in the field of medical imaging. Minimally invasive tumor treatment equipment and medical center molecular sieve oxygen equipment and engineering are the company's two core business segments.
High-end medical localization concept stock list:
Neusoft Group (600718), JiuAn medical (002432), Kewa Biological (002022), Ribbon Instruments (300206), BaoLite (300246), and good shares (300273), Xinhua Medical (600587)